[go: up one dir, main page]

MX2016007988A - Nuevo compuesto para el tratamiento de hipoglucemia severa. - Google Patents

Nuevo compuesto para el tratamiento de hipoglucemia severa.

Info

Publication number
MX2016007988A
MX2016007988A MX2016007988A MX2016007988A MX2016007988A MX 2016007988 A MX2016007988 A MX 2016007988A MX 2016007988 A MX2016007988 A MX 2016007988A MX 2016007988 A MX2016007988 A MX 2016007988A MX 2016007988 A MX2016007988 A MX 2016007988A
Authority
MX
Mexico
Prior art keywords
treatment
novel compound
severe hypoglycemia
hypoglycemia
severe
Prior art date
Application number
MX2016007988A
Other languages
English (en)
Inventor
Alsina-Fernandez Jorge
Chadwick Cummins Robert
Guo Lili
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52273565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016007988(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2016007988A publication Critical patent/MX2016007988A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere a un nuevo compuesto útil en el tratamiento de hipoglucemia.
MX2016007988A 2013-12-18 2014-12-11 Nuevo compuesto para el tratamiento de hipoglucemia severa. MX2016007988A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361917716P 2013-12-18 2013-12-18
PCT/US2014/069644 WO2015094876A1 (en) 2013-12-18 2014-12-11 Novel compound for treatment of severe hypoglycemia

Publications (1)

Publication Number Publication Date
MX2016007988A true MX2016007988A (es) 2016-09-09

Family

ID=52273565

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016007988A MX2016007988A (es) 2013-12-18 2014-12-11 Nuevo compuesto para el tratamiento de hipoglucemia severa.

Country Status (22)

Country Link
US (1) US20160311882A1 (es)
EP (1) EP3083667A1 (es)
KR (1) KR20160075826A (es)
CN (1) CN105829340A (es)
AP (1) AP2016009267A0 (es)
AR (1) AR098615A1 (es)
AU (1) AU2014366425B2 (es)
BR (1) BR112016010635A2 (es)
CA (1) CA2930596A1 (es)
CR (1) CR20160227A (es)
DO (1) DOP2016000142A (es)
EA (1) EA201690966A1 (es)
HK (1) HK1224305A1 (es)
IL (1) IL245491A0 (es)
MA (1) MA39110B1 (es)
MX (1) MX2016007988A (es)
PE (1) PE20160847A1 (es)
PH (1) PH12016501183A1 (es)
SG (1) SG11201604237PA (es)
TN (1) TN2016000208A1 (es)
TW (1) TW201609128A (es)
WO (1) WO2015094876A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI622596B (zh) 2015-10-26 2018-05-01 美國禮來大藥廠 升糖素受體促效劑
WO2019140024A1 (en) 2018-01-12 2019-07-18 Eli Lilly And Company Combination therapy
WO2020163125A1 (en) 2019-02-05 2020-08-13 Eli Lilly And Company Glucagon analog agonists and methods of using the same
WO2020201280A1 (en) 2019-04-01 2020-10-08 Novo Nordisk A/S Antibodies directed against liraglutide and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008086086A2 (en) 2007-01-05 2008-07-17 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility in physiological ph buffers
CN101983066B (zh) * 2008-01-30 2016-06-29 印第安那大学科技研究公司 基于酯的胰岛素前药
KR20110039230A (ko) * 2008-06-17 2011-04-15 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 생리학적 pH 완충액에서 강화된 용해도 및 안정성을 나타내는 글루카곤 유사체
US8703701B2 (en) * 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
DK3878859T5 (da) * 2011-06-10 2024-06-10 Hanmi Science Co Ltd Hidtil ukendte oxyntomodulinderivater og farmaceutisk præparat til behandling af fedme omfattende disse
WO2013004983A1 (en) * 2011-07-04 2013-01-10 Imperial Innovations Limited Novel compounds and their effects on feeding behaviour

Also Published As

Publication number Publication date
TW201609128A (zh) 2016-03-16
AP2016009267A0 (en) 2016-06-30
DOP2016000142A (es) 2016-07-15
AU2014366425A1 (en) 2016-05-26
US20160311882A1 (en) 2016-10-27
MA39110A1 (fr) 2017-09-29
SG11201604237PA (en) 2016-07-28
CN105829340A (zh) 2016-08-03
EA201690966A1 (ru) 2016-12-30
CR20160227A (es) 2016-07-12
EP3083667A1 (en) 2016-10-26
PH12016501183A1 (en) 2016-07-25
AU2014366425B2 (en) 2016-12-08
BR112016010635A2 (pt) 2017-12-05
WO2015094876A1 (en) 2015-06-25
CA2930596A1 (en) 2015-06-25
IL245491A0 (en) 2016-06-30
MA39110B1 (fr) 2018-04-30
AR098615A1 (es) 2016-06-01
KR20160075826A (ko) 2016-06-29
HK1224305A1 (zh) 2017-08-18
PE20160847A1 (es) 2016-09-10
TN2016000208A1 (en) 2017-10-06

Similar Documents

Publication Publication Date Title
IN2015DN00598A (es)
IN2013DE00266A (es)
IN2014DE01038A (es)
MX2015008829A (es) Momelotinib deuterado.
CL2015002358A1 (es) Compuestos bicíclicos.
AU2014224814A8 (en) Novel halogen-substituted compounds
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
MX2015012610A (es) Pacritinib deuterizado.
IN2013CH05395A (es)
UA80618U (en) Use of n-steroylethanolamine as radiomodifier
IN2015KN00386A (es)
UA72478U (ru) Применение полентара как средства фригопротекторного действия
AU350093S (en) Compact
UA103980C2 (ru) Способ консервативного лечения апоплексии яичника с минимальным гемоперитонеумом
UA91886U (uk) 1-трет-бутокси-3-(2,2,6,6-тетраметил-4-гідроксипіперидино)-2-пропанол